DK1819366T4 - Bejdsesammensætning til bejdsning af en ophthalmisk membran - Google Patents
Bejdsesammensætning til bejdsning af en ophthalmisk membran Download PDFInfo
- Publication number
- DK1819366T4 DK1819366T4 DK05814729.9T DK05814729T DK1819366T4 DK 1819366 T4 DK1819366 T4 DK 1819366T4 DK 05814729 T DK05814729 T DK 05814729T DK 1819366 T4 DK1819366 T4 DK 1819366T4
- Authority
- DK
- Denmark
- Prior art keywords
- bbg
- staining
- ophthalmic
- membrane
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Optics & Photonics (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Eyeglasses (AREA)
Claims (6)
1. Bejdsesammensætning til anvendelse i en ophthalmisk kirurgisk fremgangsmåde, som omfatter bejdsning af en ophthalmisk membran og fjernelse af den ophthalmiske membran, hvor bejdsesammensætningen omfatter Brilliant Blue G (BBG), et farmaceutisk acceptabelt salt af BBG eller et hydrat af Brilliant Blue G (BBG) som en primær bestanddel.
2. Bejdsesammensætning til anvendelse ifølge krav 1, hvor den opthalmiske membran er den interne begrænsende membran (ILM).
3. Bejdsesammensætning til anvendelse ifølge krav 1, hvor den ophtalmiske membran er den forreste kapsel.
4. Bejdsesammensætning til anvendelse ifølge krav 1, hvor bejdsesammensætningen har en koncentration af BBG, et farmaceutisk salt af BBG eller et hydrat af BBG inden for området af 0,1 mg/ml til 1,0 mg/ml.
5. Bejdsesammensætning til anvendelse ifølge krav 1, hvor bejdsesammensætningen har en koncentration af BBG, et farmaceutisk acceptabelt salt af BBG eller et hydrat af BBG inden for området af 0,1 mg/ml til 0,25 mg/ml.
6. Bejdsesammensætning til anvendelse ifølge krav 1, hvor bejdsesammensætningen har et osmotisk tryk på ca. 298 mOsm, hvilket er det samme som for en saltopløsning.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63359204P | 2004-12-06 | 2004-12-06 | |
US64750405P | 2005-01-27 | 2005-01-27 | |
PCT/JP2005/022738 WO2006062233A1 (en) | 2004-12-06 | 2005-12-06 | A staining composition for staining an ophthalmic membrane |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1819366T3 DK1819366T3 (da) | 2009-07-13 |
DK1819366T4 true DK1819366T4 (da) | 2016-09-12 |
Family
ID=36578043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05814729.9T DK1819366T4 (da) | 2004-12-06 | 2005-12-06 | Bejdsesammensætning til bejdsning af en ophthalmisk membran |
Country Status (14)
Country | Link |
---|---|
US (1) | US7731941B2 (da) |
EP (1) | EP1819366B2 (da) |
JP (1) | JP4200222B2 (da) |
CN (1) | CN101132814B (da) |
AT (1) | ATE425769T2 (da) |
CA (1) | CA2590388C (da) |
DE (1) | DE602005013423D1 (da) |
DK (1) | DK1819366T4 (da) |
ES (1) | ES2324485T5 (da) |
HK (1) | HK1101677A1 (da) |
IL (1) | IL183087A (da) |
PL (1) | PL1819366T5 (da) |
PT (1) | PT1819366E (da) |
WO (1) | WO2006062233A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101678042A (zh) * | 2007-04-06 | 2010-03-24 | 千寿制药株式会社 | 眼部透明组织可视化用混悬剂 |
DE102008064065B9 (de) * | 2008-12-19 | 2011-01-05 | Fluoron Gmbh | Farbstofflösung |
WO2010074326A1 (en) * | 2008-12-25 | 2010-07-01 | Canon Kabushiki Kaisha | Probe for a biological specimen and labelling method and screening method using the probe |
WO2010074325A1 (en) | 2008-12-25 | 2010-07-01 | Canon Kabushiki Kaisha | Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method |
DE102009056597A1 (de) | 2009-12-02 | 2011-06-09 | Tobias Brockmann | Verwendung von Flavin-Derivaten zur Behandlung von Pathologien an der Membrana limitans interna (ILM) |
ES2670818T3 (es) * | 2010-04-01 | 2018-06-01 | D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. | Composición de tinción para usar en un método de cirugía ocular |
WO2012066994A1 (ja) | 2010-11-15 | 2012-05-24 | 国立大学法人九州大学 | 神経保護作用を持つ薬剤配合 |
FR2980363B1 (fr) * | 2011-09-22 | 2014-11-28 | Arcadophta | Composition a toxicite reduite d'au moins un colorant stable et pouvant etre sterilisee |
ITMI20120355A1 (it) | 2012-03-07 | 2013-09-08 | Ciro Caruso | Sostanza colorante per uso diagnostico oftalmologico |
DE102012103097A1 (de) * | 2012-04-11 | 2013-10-17 | Fluoron Gmbh | Färbemittel zum Einfärben einer ophthalmischen Membran |
US20130272962A1 (en) * | 2012-04-11 | 2013-10-17 | Fluoron Gmbh | Staining agent for corneal staining |
ES2857751T3 (es) | 2013-10-11 | 2021-09-29 | Massachusetts Eye & Ear Infirmary | Métodos para predecir secuencias de virus ancestrales y usos de los mismos |
EP3291765A4 (en) | 2015-05-07 | 2019-01-23 | Massachusetts Eye & Ear Infirmary | METHODS OF DELIVERING AN AGENT TO THE EYE |
ITUB20150864A1 (it) * | 2015-05-26 | 2016-11-26 | Al Chi Mi A S R L | Molecola colorante e composizioni coloranti, in particolare per uso in metodi chirurgici di chirurgia oftalmica e per la colorazione di proteine |
JP5987102B1 (ja) | 2015-11-27 | 2016-09-06 | 株式会社ヘリオス | トリアリールメタン組成物,眼膜染色のための染色組成物 |
CA2965904A1 (en) * | 2016-05-02 | 2017-11-02 | James M. Rynerson | Methods and devices for detecting biofilms on the eyelid margin |
WO2019068355A1 (en) | 2017-10-06 | 2019-04-11 | Alfa Instruments S.R.L. | BLUE GLYING (BBG) COLOR DERIVATIVES AND COLORING COMPOUNDS COMPRISING THEM FOR SELECTIVELY COLORING BIOLOGICAL SUBSTRATES |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5132439A (en) * | 1990-11-19 | 1992-07-21 | Promega Corporation | Protein staining compositions and methods |
JPH05310580A (ja) * | 1992-04-30 | 1993-11-22 | Shiseido Co Ltd | 眼内灌流用液剤 |
JPH0797331A (ja) * | 1993-06-07 | 1995-04-11 | Senju Pharmaceut Co Ltd | 眼内灌流液 |
JP3228699B2 (ja) * | 1997-04-22 | 2001-11-12 | 株式会社オフテクス | 眼手術用灌流液製剤 |
US6057160A (en) * | 1997-08-06 | 2000-05-02 | Washington State University Research Foundation | Methods for preparation and use of a coomassie brilliant blue/protein complex |
AU1596099A (en) * | 1998-11-23 | 2000-06-13 | Eisai Co. Ltd. | Aryl and heteroaryl compounds useful as fibroblast growth factor antagonists |
JP3953322B2 (ja) * | 1999-07-09 | 2007-08-08 | コロネオ・ミナス・セオドール | 眼球の前部水晶体嚢を可視化するためのトリパンブルーの使用 |
AUPQ155799A0 (en) * | 1999-07-09 | 1999-08-05 | Coroneo, Minas Theodore | Therapeutic methods and uses |
US6367480B1 (en) * | 1999-07-09 | 2002-04-09 | Minas Theodore Coroneo | Methods for visualizing the anterior lens capsule of the human eye |
DE10255601C5 (de) * | 2002-10-14 | 2017-10-19 | Fluoron Gmbh | Verwendung eines Triphenylmethanfarbstoffs zur Herstellung eines Färbemittels bei der Netzhaut- und Glaskörperchirurgie |
-
2005
- 2005-12-06 DE DE602005013423T patent/DE602005013423D1/de active Active
- 2005-12-06 ES ES05814729.9T patent/ES2324485T5/es active Active
- 2005-12-06 US US11/792,462 patent/US7731941B2/en active Active
- 2005-12-06 PL PL05814729T patent/PL1819366T5/pl unknown
- 2005-12-06 AT AT05814729T patent/ATE425769T2/de active
- 2005-12-06 PT PT05814729T patent/PT1819366E/pt unknown
- 2005-12-06 DK DK05814729.9T patent/DK1819366T4/da active
- 2005-12-06 JP JP2007525890A patent/JP4200222B2/ja active Active
- 2005-12-06 CA CA2590388A patent/CA2590388C/en active Active
- 2005-12-06 WO PCT/JP2005/022738 patent/WO2006062233A1/en active Search and Examination
- 2005-12-06 EP EP05814729.9A patent/EP1819366B2/en active Active
- 2005-12-06 CN CN2005800416779A patent/CN101132814B/zh active Active
-
2007
- 2007-05-09 IL IL183087A patent/IL183087A/en active IP Right Grant
- 2007-09-05 HK HK07109680.9A patent/HK1101677A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101132814A (zh) | 2008-02-27 |
EP1819366A4 (en) | 2008-04-16 |
ATE425769T2 (de) | 2009-04-15 |
PT1819366E (pt) | 2009-06-25 |
JP2008522953A (ja) | 2008-07-03 |
DK1819366T3 (da) | 2009-07-13 |
ES2324485T3 (es) | 2009-08-07 |
HK1101677A1 (en) | 2007-10-26 |
CN101132814B (zh) | 2010-08-04 |
CA2590388A1 (en) | 2006-06-15 |
EP1819366B2 (en) | 2016-06-22 |
PL1819366T5 (pl) | 2017-04-28 |
US7731941B2 (en) | 2010-06-08 |
JP4200222B2 (ja) | 2008-12-24 |
EP1819366A1 (en) | 2007-08-22 |
EP1819366B1 (en) | 2009-03-18 |
ES2324485T5 (es) | 2016-11-17 |
IL183087A (en) | 2012-01-31 |
WO2006062233A1 (en) | 2006-06-15 |
US20080090914A1 (en) | 2008-04-17 |
PL1819366T3 (pl) | 2009-08-31 |
DE602005013423D1 (de) | 2009-04-30 |
CA2590388C (en) | 2010-11-09 |
IL183087A0 (en) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1819366T4 (da) | Bejdsesammensætning til bejdsning af en ophthalmisk membran | |
Rodrigues et al. | The use of vital dyes in ocular surgery | |
Gass et al. | Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane | |
Teba et al. | Trypan blue staining in vitreoretinal surgery | |
Kwok et al. | Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries | |
Enaida et al. | Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G | |
Rodrigues et al. | Vital dyes for chromovitrectomy | |
Leonard et al. | Clinicopathologic correlation of localized retinal pigment epithelium debridement. | |
Rodrigues et al. | Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes | |
JP3469199B2 (ja) | 白内障摘出の外科手術手技を容易にする生体染色色素の使用 | |
US20080206149A1 (en) | Method, dye and medicament for staining the internal limiting membrane, epiretinal membrane, the vitreous and/or the capsule of an eye | |
Sawa et al. | Nonvitrectomizing vitreous surgery for epiretinal membrane: long-term follow-up | |
EP2620144A1 (en) | Staining Composition | |
Farah et al. | Current concepts of trypan blue in chromovitrectomy | |
TW201410245A (zh) | 治療用調合物及治療方法 | |
Penha et al. | Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits | |
Lanzetta et al. | Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane | |
Brockmann et al. | Ultrastructure of the membrana limitans interna after dye-assisted membrane peeling | |
Torres-Villaros et al. | Macular toxicity of vital dye after pars plana vitrectomy for idiopathic epiretinal membrane: A case report | |
Nagai et al. | Surgical effects and complications of indocyanine green‐assisted internal limiting membrane peeling for idiopathic macular hole | |
Ashikari et al. | Long-term retention of dye after indocyanine green-assisted internal limiting membrane peeling | |
Haritoglou et al. | An experimental approach towards novel dyes for intraocular surgery | |
Sarfare et al. | Biocompatibility of a synthetic biopolymer for the treatment of rhegmatogenous retinal detachment | |
Vidal-Sanz et al. | Retinal ischemia | |
Chao et al. | Retinal function and histologic changes following intravitreal injection of indocyanine green in a rabbit model |